The Physician and Sportsmedicine
Menubar Home Journal Personal Health Resource Center CME Advertiser Services About Us
Resources on Metabolic Syndrome

THE PHYSICIAN AND SPORTSMEDICINE - VOL 32 - NO. 1 - JANUARY 2004


Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med, 2003:157(8):821-7

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(3):2486-97

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287(3):356-9

Haffner S, Taegtmeyer H. Epidemic obesity and metabolic syndrome. Circulation 2003;108():1541-5

Katzmarzyk PT, Leon AS, Wilmore JH, et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc 2003;35(10):1703-9

Kereiakes DJ, Willerson JT. The metabolic syndrome epidemic. Circulation 2003;108(13):1552-3

National Heart, Lung, and Blood Institute Obesity Education Initiative. Identification, evaluation, and treatment of overweight and obesity in adults. The practical guide. Bethesda, Md: National Institutes of Health, 2001; NIH publication 00-4084

Reilly MP, Rader DJ. The metabolic syndrome: More than the sum of its parts? Circulation 2003;108(13):1546-51

Tataranni PA, Bogardus C. Changing habits to delay diabetes. (Editorial) N Engl J Med 2001;344(18):1390-1

The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981-97

The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA 2002;288(23):2998-3007

The seventh report of the Joint National Committee for the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health, 2003; NIH publication 03-5233

The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. Available at: https://www.surgeongeneral.gov/topics/obesity/. Accessed Nov 3, 2003

Tuomilehto J, Lindstrom J, Eriksson JG, et al, for the Finnish Diabetes Prevention Study. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50

Wilson PW, Grundy SM. The metabolic syndrome: practical guide to origins and treatment. Part I. Circulation 2003;108(12):1422-5

Wilson PW, Grundy SM. The metabolic syndrome: A practical guide to origins and treatment. Part II. Circulation 2003;108(13):1537-40


RETURN TO JANUARY 2004 TABLE OF CONTENTS

HOME  |   JOURNAL  |   PERSONAL HEALTH  |   RESOURCE CENTER  |   CME  |   ADVERTISER SERVICES  |   ABOUT US  |   SEARCH